Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- Less than 20% of IRBs Utilize Central IRB Despite Revised GCP Ordinance: Dr Narumoto of Okayama Univ.
December 5, 2012
- Need for Corporate Seminars May Depend on “Doctors’ Abilities”: NIRS Senior Researcher Kurihara
November 30, 2012
- AASD Scientific Meeting Shines Light on SGLT-2 Inhibitors as Next Generation Diabetes Treatment
November 28, 2012
- New Hoshi General Hospital to Give Patients Option of In-House or Legal Prescriptions Starting in January
November 22, 2012
- J-ADNI2 to Go Forward in Search of New Treatment for AD: Prof. Iwatsubo of Univ. of Tokyo
November 19, 2012
- New COPD GLs to Recommend LAMA, LABA Equally: Prof. Nagai of Tokyo Women’s Medical University
October 22, 2012
- Biosimilars Should Be Mentioned in Government Roadmap: JSGM President Muto
October 18, 2012
- Supercomputer to Dramatically Shorten Exploratory Period for Lead Compounds: Prof. Fujitani of University of Tokyo
October 16, 2012
- We Would Like to Provide iPS Cells with Medical History Identification: Prof. Yamanaka of Kyoto University
October 15, 2012
- JAOG Insists on Introduction of HPV Testing to Cervical Cancer Screening
September 14, 2012
- CRND Initiates Clinical Research, Showing Willingness for Company-Sponsored Studies
September 6, 2012
- Incidence of CVD Decreases More in High-Risk Patients with Lower LDL-C during Pravastatin Treatment
July 26, 2012
- 95% of Japanese-Bound Online Drug Sales “Rogue”: LegitScript Survey
July 26, 2012
- Takeda’s TAK-070 for AD Worthy of Clinical Trial: Prof. Iwatsubo of Univ. of Tokyo Hospital
July 18, 2012
- Inlyta Can Be 1st-Choice in 2nd-Line Therapy: Prof. Uemura of Kinki Univ.
July 13, 2012
- Minirinmelt Most Effective for Nocturnal Enuresis, But Precaution for Water Intoxication Needed: Prof. Kaneko
July 11, 2012
- Drug Damage Watchdog Calls for Halt to Easing of Safety Management Procedures for Thalidomide
June 28, 2012
- Univ. of Tokyo Hospital’s New “Phase I Unit” to Initiate Trials for Takeda’s TAK-070 for AD
June 28, 2012
- JSGM Discuss Prices for Long-Listed Products and GEs, Say Unified Prices Could Ruin GE Business
June 26, 2012
- RIKEN, NCC Succeed at Visualizing Kinetics of Trastuzumab in HER2-Positive Breast Cancer Patients
June 7, 2012
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…